Amoy Diagnostics Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000034D3
CNY
22.30
1.05 (4.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,103.95
1,038.84
838.46
912.86
725.03
574.61
436.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,103.95
1,038.84
838.46
912.86
725.03
574.61
436.30
Raw Material Cost
216.62
215.26
188.39
174.89
118.70
76.89
55.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.69
1.57
1.40
0.80
1.29
0.25
0.74
Selling and Distribution Expenses
421.60
377.74
352.05
362.85
329.30
285.69
192.50
Other Expenses
18.89
17.58
15.41
13.99
9.99
8.10
6.97
Total Expenditure (Excl Depreciation)
828.81
770.38
695.95
678.46
549.19
443.79
318.80
Operating Profit (PBDIT) excl Other Income
275.1
268.5
142.5
234.4
175.79999999999998
130.8
117.5
Other Income
45.30
45.74
150.16
16.15
31.33
37.02
27.70
Operating Profit (PBDIT)
379.55
373.35
346.05
290.27
235.57
193.35
165.93
Interest
1.69
1.57
1.40
0.80
1.29
0.25
0.74
Exceptional Items
-17.19
-4.96
4.57
5.58
0.33
-0.00
0.09
Gross Profit (PBDT)
887.33
823.58
650.07
737.96
606.33
497.72
380.43
Depreciation
59.11
59.16
53.24
39.67
28.31
25.49
20.73
Profit Before Tax
301.56
307.67
295.98
255.38
206.31
167.60
144.55
Tax
35.02
33.37
21.79
12.95
20.38
25.88
15.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
254.86
261.48
263.74
239.57
180.33
135.47
126.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
254.86
261.48
263.74
239.57
180.33
135.47
126.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.55
-0.55
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
254.86
261.48
264.29
239.02
180.33
135.47
126.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,843.26
1,703.32
1,499.73
1,364.58
1,128.49
902.11
756.74
Earnings per share (EPS)
0.65
0.66
0.67
0.6
0.45
0.35
0.33
Diluted Earnings per share
0.65
0.66
0.67
0.6
0.45
0.35
0.33
Operating Profit Margin (Excl OI)
24.92%
25.84%
17.01%
25.68%
24.26%
22.77%
26.93%
Gross Profit Margin
32.67%
35.31%
41.65%
32.32%
32.36%
33.6%
37.88%
PAT Margin
23.09%
25.17%
31.46%
26.24%
24.87%
23.58%
29.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.27% vs 23.89% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -2.52% vs -1.06% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 2.05% vs 67.23% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 6.25% vs 14.29% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Amoy Diagnostics Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,103.95
0
1,103.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,103.95
0
1,103.95
Raw Material Cost
216.62
0
216.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.69
0
1.69
Selling and Distribution Expenses
421.60
0
421.60
Other Expenses
18.89
0.00
18.89
Total Expenditure (Excl Depreciation)
828.81
0
828.81
Operating Profit (PBDIT) excl Other Income
275.14
0.00
275.14
Other Income
45.30
0
45.30
Operating Profit (PBDIT)
379.55
0
379.55
Interest
1.69
0
1.69
Exceptional Items
-17.19
0
-17.19
Gross Profit (PBDT)
887.33
0
887.33
Depreciation
59.11
0
59.11
Profit Before Tax
301.56
0
301.56
Tax
35.02
0
35.02
Provisions and contingencies
0
0
0.00
Profit After Tax
254.86
0
254.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
254.86
0
254.86
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
254.86
0
254.86
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,843.26
0
1,843.26
Earnings per share (EPS)
0.65
0
0.65
Diluted Earnings per share
0.65
0
0.65
Operating Profit Margin (Excl OI)
24.92%
0%
0.00
24.92%
Gross Profit Margin
32.67%
0%
0.00
32.67%
PAT Margin
23.09%
0%
0.00
23.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 110.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.27% vs 23.89% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 25.49 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.52% vs -1.06% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.43 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.05% vs 67.23% in Dec 2023

Annual - Interest
Interest 0.17 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.25% vs 14.29% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023